Total cholesterol | Triglyceride | HDL-C | a LDL-C | |||||
---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | |
Urinary ttMA | ||||||||
Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Q2 | 0.00 (-0.02, 0.03) | -0.01 (-0.03, 0.02) | 0.14 (0.05, 0.23) | 0.08 (0.01, 0.15) | -0.03 (-0.06, 0.01) | -0.01 (-0.04, 0.02) | -0.03 (-0.07, 0.01) | -0.05 (-0.08, -0.01) |
Q3 | -0.01 (-0.03, 0.01) | -0.01 (-0.04, 0.01) | 0.10 (0.01, 0.18) | 0.04 (-0.03, 0.11) | 0.01 (-0.02, 0.05) | 0.02 (-0.01, 0.05) | -0.06 (-0.10, -0.02) | -0.06 (-0.10, -0.03) |
Q4 | 0.00 (-0.02, 0.02) | -0.01 (-0.03, 0.02) | 0.19 (0.12, 0.27) | 0.13 (0.06, 0.20) | -0.01 (-0.04, 0.03) | -0.01 (-0.04, 0.03) | -0.05 (-0.09, -0.02) | -0.06 (-0.10, -0.02) |
p for trend | 0.932 | 0.979 | 0.225 | 0.159 | 0.186 | 0.853 | 0.325 | < 0.001 |
Urinary BMA | ||||||||
Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Q2 | -0.01 (-0.03, 0.01) | -0.01 (-0.03, 0.01) | -0.01 (-0.08, 0.07) | 0.06 (-0.01, 0.12) | 0.05 (0.01, 0.08) | 0.02 (-0.01, 0.05) | -0.03 (-0.07, 0.01) | -0.04 (-0.08, -0.01) |
Q3 | 0.00 (-0.02, 0.02) | -0.02 (-0.04, -0.01) | 0.01 (-0.06, 0.09) | 0.06 (-0.01, 0.11) | 0.06 (0.03, 0.10) | 0.04 (0.01, 0.07) | -0.05 (-0.09, -0.01) | -0.09 (-0.13, -0.05) |
Q4 | -0.03 (-0.05, -0.01) | -0.04 (-0.06, -0.01) | -0.02 (-0.11, 0.06) | 0.03 (-0.03, 0.10) | 0.05 (0.01, 0.08) | 0.02 (-0.01, 0.06) | -0.07 (-0.12, -0.02) | -0.10 (-0.14, -0.05) |
p for trend | 0.055 | < 0.001 | 0.684 | 0.361 | 0.989 | 0.052 | 0.115 | < 0.001 |
aParticipants with TG levels > 400 mg/dL were excluded from LDL-C analysis (n = 3230). Adjusted model was adjusted for age, sex, BMI, education level, marital status, household income level, smoking, alcohol consumption and exercise. ttMA, trans,trans-muconic acid; BMA, benzylmercapturic acid; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein |